258 related articles for article (PubMed ID: 34375173)
61. Activatable nanomedicine for overcoming hypoxia-induced resistance to chemotherapy and inhibiting tumor growth by inducing collaborative apoptosis and ferroptosis in solid tumors.
Fu J; Li T; Yang Y; Jiang L; Wang W; Fu L; Zhu Y; Hao Y
Biomaterials; 2021 Jan; 268():120537. PubMed ID: 33260096
[TBL] [Abstract][Full Text] [Related]
62. Lipoxygenase-mediated generation of lipid peroxides enhances ferroptosis induced by erastin and RSL3.
Shintoku R; Takigawa Y; Yamada K; Kubota C; Yoshimoto Y; Takeuchi T; Koshiishi I; Torii S
Cancer Sci; 2017 Nov; 108(11):2187-2194. PubMed ID: 28837253
[TBL] [Abstract][Full Text] [Related]
63. Modulations of ferroptosis in lung cancer therapy.
Walters R; Mousa SA
Expert Opin Ther Targets; 2022 Feb; 26(2):133-143. PubMed ID: 35061567
[TBL] [Abstract][Full Text] [Related]
64. Irisin Is a Positive Regulator for Ferroptosis in Pancreatic Cancer.
Yang BC; Leung PS
Mol Ther Oncolytics; 2020 Sep; 18():457-466. PubMed ID: 32953980
[TBL] [Abstract][Full Text] [Related]
65. The Protective Role of Mitochondrial Ferritin on Erastin-Induced Ferroptosis.
Wang YQ; Chang SY; Wu Q; Gou YJ; Jia L; Cui YM; Yu P; Shi ZH; Wu WS; Gao G; Chang YZ
Front Aging Neurosci; 2016; 8():308. PubMed ID: 28066232
[TBL] [Abstract][Full Text] [Related]
66. Phosphocatalytic Kinome Activity Profiling of Apoptotic and Ferroptotic Agents in Multiple Myeloma Cells.
Logie E; Novo CP; Driesen A; Van Vlierberghe P; Vanden Berghe W
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884535
[TBL] [Abstract][Full Text] [Related]
67. Molecular mechanisms of ferroptosis and its role in cancer therapy.
Xu T; Ding W; Ji X; Ao X; Liu Y; Yu W; Wang J
J Cell Mol Med; 2019 Aug; 23(8):4900-4912. PubMed ID: 31232522
[TBL] [Abstract][Full Text] [Related]
68. GSK-3β manipulates ferroptosis sensitivity by dominating iron homeostasis.
Wang L; Ouyang S; Li B; Wu H; Wang F
Cell Death Discov; 2021 Nov; 7(1):334. PubMed ID: 34732689
[TBL] [Abstract][Full Text] [Related]
69. Ferroptosis is a type of autophagy-dependent cell death.
Zhou B; Liu J; Kang R; Klionsky DJ; Kroemer G; Tang D
Semin Cancer Biol; 2020 Nov; 66():89-100. PubMed ID: 30880243
[TBL] [Abstract][Full Text] [Related]
70. Harnessing the Potential of Non-Apoptotic Cell Death Processes in the Treatment of Drug-Resistant Melanoma.
Dong L; Vargas CPD; Tian X; Chu X; Yin C; Wong A; Yang Y
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373523
[TBL] [Abstract][Full Text] [Related]
71. Nanotechnology-integrated ferroptosis inducers: a sharp sword against tumor drug resistance.
Li C; Wu X; Zheng C; Xu S; Liu Y; Qin J; Fan X; Ye Y; Fei W
J Mater Chem B; 2022 Oct; 10(38):7671-7693. PubMed ID: 36043505
[TBL] [Abstract][Full Text] [Related]
72. Role of targeting ferroptosis as a component of combination therapy in combating drug resistance in colorectal cancer.
Xie XT; Pang QH; Luo LX
World J Clin Oncol; 2024 Mar; 15(3):375-377. PubMed ID: 38576594
[TBL] [Abstract][Full Text] [Related]
73. Ferroptosis: Final destination for cancer?
Ye Z; Liu W; Zhuo Q; Hu Q; Liu M; Sun Q; Zhang Z; Fan G; Xu W; Ji S; Yu X; Qin Y; Xu X
Cell Prolif; 2020 Mar; 53(3):e12761. PubMed ID: 32100402
[TBL] [Abstract][Full Text] [Related]
74. Roles of ferroptosis in urologic malignancies.
Zhao S; Li P; Wu W; Wang Q; Qian B; Li X; Shen M
Cancer Cell Int; 2021 Dec; 21(1):676. PubMed ID: 34922551
[TBL] [Abstract][Full Text] [Related]
75. The Role of Erastin in Ferroptosis and Its Prospects in Cancer Therapy.
Zhao Y; Li Y; Zhang R; Wang F; Wang T; Jiao Y
Onco Targets Ther; 2020; 13():5429-5441. PubMed ID: 32606760
[TBL] [Abstract][Full Text] [Related]
76. Transcription factors in ferroptotic cell death.
Dai C; Chen X; Li J; Comish P; Kang R; Tang D
Cancer Gene Ther; 2020 Sep; 27(9):645-656. PubMed ID: 32123318
[TBL] [Abstract][Full Text] [Related]
77. Ferroptosis: Cancer Stem Cells Rely on Iron until "to Die for" It.
Cosialls E; El Hage R; Dos Santos L; Gong C; Mehrpour M; Hamaï A
Cells; 2021 Nov; 10(11):. PubMed ID: 34831207
[TBL] [Abstract][Full Text] [Related]
78. Cell growth potential drives ferroptosis susceptibility in rhabdomyosarcoma and myoblast cell lines.
Codenotti S; Poli M; Asperti M; Zizioli D; Marampon F; Fanzani A
J Cancer Res Clin Oncol; 2018 Sep; 144(9):1717-1730. PubMed ID: 29971532
[TBL] [Abstract][Full Text] [Related]
79. Bioinorganic Modulators of Ferroptosis: A Review of Recent Findings.
Bartos A; Sikora J
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835045
[TBL] [Abstract][Full Text] [Related]
80. CISD1 inhibits ferroptosis by protection against mitochondrial lipid peroxidation.
Yuan H; Li X; Zhang X; Kang R; Tang D
Biochem Biophys Res Commun; 2016 Sep; 478(2):838-44. PubMed ID: 27510639
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
